Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 23;56(9):425.
doi: 10.3390/medicina56090425.

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease

Smaranda Diaconescu  1   2 , Silvia Strat  2 , Gheorghe G Balan  3   4 , Carmen Anton  3   4 , Gabriela Stefanescu  3   4 , Ileana Ioniuc  1   5 , Ana Maria Alexandra Stanescu  6
Affiliations

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease

Smaranda Diaconescu et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Over the last years, inflammatory bowel disease (IBD) has been reported on a high incidence in pediatric populations and has been associated with numerous extraintestinal manifestations, making its management a real challenge for the pediatric gastroenterologist. Dermatological manifestations in IBD are either specific, related to the disease activity or treatment-associated, or non-specific. This literature review aims to identify and report the dermatological manifestations of IBD in children, the correlation between their appearance and the demographical characteristics, the relationship between these lesions and disease activity, and to highlight the impact of dermatological manifestations on an IBD treatment regime.

Materials and methods: A systemic literature review was performed, investigating articles and case reports on dermatological manifestations in children with IBD starting from 2005. A total of 159 potentially suitable articles were identified and after the exclusion process, 75 articles were selected.

Results: The most common dermatological manifestations reported in pediatric IBD are erythema nodosum and pyoderma gangrenosum. More rare cases of metastatic Crohn's disease, epidermolysis bullosa acquisita, small-vessel vasculitis, necrotizing vasculitis, leukocytoclastic vasculitis, cutaneous polyarteritis nodosa, and Sweet's syndrome have been reported. Oral manifestations of IBD are divided into specific (tag-like lesions, mucogingivitis, lip swelling with vertical fissures, aphthous stomatitis, and pyostomatitis vegetans) and non-specific. IBD treatment may present with side effects involving the skin and mucosa. Anti-tumor necrosis factor agents have been linked to opportunistic skin infections, psoriasiform lesions, and a potentially increased risk for skin cancer. Cutaneous manifestations such as acrodermatitis enteropathica, purpuric lesions, and angular cheilitis may appear secondary to malnutrition and/or malabsorption.

Conclusions: The correct diagnosis of dermatological manifestations in pediatric IBD is of paramount importance because of their impact on disease activity, treatment options, and a patient's psychological status.

Keywords: Crohn’s disease; dermatological; pediatric; treatment; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The PRISMA flow diagram, adapted from [6].
See this image and copyright information in PMC

References

    1. Turner D., Ruemmele F.M., Orlanski-Meyer E., Griffiths A.M., Martin de Carpi J., Bronsky J., Veres G., Aloi M., Strisciuglio C., Braegger C.P., et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline from European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J. Pediatric Gastroenterol. Nutr. 2018;67:257–291. doi: 10.1097/MPG.0000000000002035. - DOI - PubMed
    1. Levine A., Koletzko S., Turner D., Escher J.C., Cucchiara S., de Ridder L., Kolho K.L., Veres G., Russell R.K., Paerregaard A., et al. ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents. J. Pediatric Gastroenterol. Nutr. 2014;58:795–806. doi: 10.1097/MPG.0000000000000239. - DOI - PubMed
    1. Jose F.A., Garnett E.A., Vittinghoff E., Ferry G.D., Winter H.S., Baldassano R.N., Kirschner B.S., Cohen S.A., Gold B.D., Abramson O., et al. Development of Extraintestinal Manifestations in Pediatric Patients With Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2009;15:63–68. doi: 10.1002/ibd.20604. - DOI - PMC - PubMed
    1. Jang H.J., Kang B., Choe B.H. The Difference in Extraintestinal Manifestations of Inflammatory Bowel Disease for Children and Adults. Transl. Pediatrics. 2019;8:4–15. doi: 10.21037/tp.2019.01.06. - DOI - PMC - PubMed
    1. Levine J.S., Burakoff R. Extraintestinal Manifestations of Inflammatory Bowel Disease. Gastroenterol. Hepatol. 2011;7:235–241. - PMC - PubMed

Publication types

MeSH terms

Substances